L575-0670 Screening compound: 4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide

L575-0670 Screening compound: 4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide
L575-0670 Screening compound: 4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L575-0670
4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L575-0670

Molecular Formula

C26H35N5O5 (C26 H35 N5 O5)

Compound Name

4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide

IUPAC name

4-[1-methyl-3-(morpholine-4-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]-4-oxo-N-{[4-(propan-2-yloxy)phenyl]methyl}butanamide

SMILES

CC(C)Oc1ccc(CNC(CCC(N(CC2)Cc3c2n(C)nc3C(N2CCOCC2)=O)=O)=O)cc1

InChI

InChI=1S/C26H35N5O5/c1-18(2)36-20-6-4-19(5-7-20)16-27-23(32)8-9-24(33)31-11-10-22-21(17-31)25(28-29(22)3)26(34)30-12-14-35-15-13-30/h4-7,18H,8-17H2,1-3H3,(H,27,32)

InChI Key

FBRBSJSVOKVPFK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27463587

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.171

Distribution Coefficient, logD

0.171

Water Solubility, LogSw

-1.88

Polar Surface Area

86.870

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

3.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

53.80

L575-0670 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L575-0670 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L575-0670?
Check Price and Availability of L575-0670, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L575-0670 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L575-0670
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L575-0670
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L575-0670 available by request